These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 10924990)
1. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990 [TBL] [Abstract][Full Text] [Related]
2. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Nag S; Chao C; Erickson B; Fowler J; Gupta N; Martinez A; Thomadsen B; Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):33-48. PubMed ID: 11777620 [TBL] [Abstract][Full Text] [Related]
3. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule. Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679 [TBL] [Abstract][Full Text] [Related]
4. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study. Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599 [TBL] [Abstract][Full Text] [Related]
5. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683 [TBL] [Abstract][Full Text] [Related]
6. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma. Lee SW; Suh CO; Chung EJ; Kim GE Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747 [TBL] [Abstract][Full Text] [Related]
7. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience. Petereit DG; Sarkaria JN; Potter DM; Schink JC Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322 [TBL] [Abstract][Full Text] [Related]
8. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Pötter R; Van Limbergen E; Gerstner N; Wambersie A Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676 [TBL] [Abstract][Full Text] [Related]
9. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Petereit DG; Pearcey R Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):359-66. PubMed ID: 10030262 [TBL] [Abstract][Full Text] [Related]
10. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Nag S; Erickson B; Parikh S; Gupta N; Varia M; Glasgow G Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):779-90. PubMed ID: 11020575 [TBL] [Abstract][Full Text] [Related]
11. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997 [TBL] [Abstract][Full Text] [Related]
12. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362 [TBL] [Abstract][Full Text] [Related]
13. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Lee LJ; Das IJ; Higgins SA; Jhingran A; Small W; Thomadsen B; Viswanathan AN; Wolfson A; Eifel P; Brachytherapy; 2012; 11(1):53-7. PubMed ID: 22265438 [TBL] [Abstract][Full Text] [Related]
14. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy. Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615 [TBL] [Abstract][Full Text] [Related]
15. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model. Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547 [TBL] [Abstract][Full Text] [Related]
16. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme. Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Changchien CC; Huang EY; Wu JM; Chen CC Int J Radiat Oncol Biol Phys; 1997 May; 38(2):391-8. PubMed ID: 9226328 [TBL] [Abstract][Full Text] [Related]
17. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794 [TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer. Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915 [TBL] [Abstract][Full Text] [Related]
19. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461 [TBL] [Abstract][Full Text] [Related]
20. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix. Kim WC; Kim GE; Suh CO; Loh JJ Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]